🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: AeroChamber Plus Flow-Vu spacer

Found 22 matching trials

A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer

PHASE1

The primary purpose of this study is to demonstrate the equivalence of bude...

Status

Withdrawn

Location

Multiple Locations

Start Date

2024-10-17

Trial ID

NCT06340581

Treatments Being Tested

Treatment A: BGF MDI HFA Treatment B: BGF MDI HFO Treatment C: BGF MDI HFO AeroChamber Plus Flow-Vu Spacer

Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients

PHASE1

The study is performed to investigate the effect of the spacing device on t...

Status

Completed

Location

Medical University in Lodz

Start Date

2014-03

Trial ID

NCT02119234

Treatments Being Tested

Beclometasone/formoterol/glycopyrrolate Placebo

Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers

PHASE4

The purpose of this study is to determine the effect of plastic spacers and...

Status

Completed

Location

Asthma & Allergy Research Group, Department of cardiovascular & lung biology, Division of medicine, Ninewells Hospital & Medical School

Start Date

2009-11

Trial ID

NCT01194700

Treatments Being Tested

Seretide 250(8puffs) via Evohaler actuator Seretide 250 (8 puffs)/placebo via Volumatic spacer Seretide 250/placebo 8 puffs via Aerochamber Plus spacer Seretide 250/placebo via Synchro-Breathe

A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010

PHASE1

Randomized, Open-label, Single-dose, Single-center, Crossover Study in Heal...

Status

Completed

Location

Pearl Investigative Site

Start Date

2017-10-17

Trial ID

NCT03311373

Treatments Being Tested

Regimen A Regimen B Regimen C Regimen D

Pilot Pharmacokinetic Clenil Study With AeroChamber Plus™ or Volumatic™ Spacer Devices

PHASE2

The purpose of this study is to evaluate, at steady-state, the systemic exp...

Status

Completed

Location

Medicines Evaluation Unit, Wythenshawe Hospital

Start Date

2011-04

Trial ID

NCT01370031

Treatments Being Tested

Clenil® Modulite® via AeroChamber Plus™Clenil® Modulite® via Volumatic™ spacer Clenil® Modulite® via AeroChamber Plus™ plus charcoal block Clenil® Modulite® administered via Volumatic™ spacer plus charcoal block

A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)

PHASE2

A study to compare the bronchodilatory effect of a single dose of Mometason...

Status

Completed

Location

Multiple Locations

Start Date

2010-12

Trial ID

NCT01258803

Treatments Being Tested

Formoterol Fumarate DPI Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) without spacer Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) with spacer Placebo MDI with spacer Placebo MDI without spacer Mometasone Furoate DPI

A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS

PHASE4

Collect PK/PD data for this age group to compare ADVAIR DISKUS with ADVAIR ...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-10

Trial ID

NCT00400608

Treatments Being Tested

ADVAIR HFA ADVAIR DISKUS

Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old

PHASE2

The rationale is to investigate the systemic availability of BDP/B17MP and ...

Status

Completed

Location

BorneAstmaKlinikken

Start Date

2009-09

Trial ID

NCT01848769

Treatments Being Tested

CHF1535 pMDI + AC Plus BDP + AC Plus Formoterol + AC Plus

Foster With or Without Charcoal Block or Aerochamber Plus

PHASE1

The purpose of this study is to evaluate the systemic exposure of BDP, its ...

Status

Completed

Location

CROSS Research SA

Start Date

2006-12

Trial ID

NCT01280175

Treatments Being Tested

charcoal block Aerochamber Plus spacer pMDI standard actuator

Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists

PHASE3

This is a study comparing CHF 5993 pMDI HFA-152a with CHF 1535 pMDI HFA-134...

Status

Recruiting

Location

China-Japan Friendship Hospital

Start Date

2026-06-26

Trial ID

NCT07546981

Treatments Being Tested

Experimental: Participant Group CHF 5993 pMDI HFA-152a Active Comparator: CHF 1535 100/6 μg pMDI HFA-134a

Previous Next